These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25093740)

  • 1. Perspectives on sudden death prevention in hypertrophic cardiomyopathy.
    Efthimiadis GK; Zegkos T; Meditskou S; Hadjimiltiades S
    Cardiol Rev; 2014; 22(5):210-6. PubMed ID: 25093740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.
    Maron BJ; Maron MS
    Heart Rhythm; 2016 May; 13(5):1155-1165. PubMed ID: 26749314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
    Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
    Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    Card Electrophysiol Clin; 2015 Jun; 7(2):165-71. PubMed ID: 26002383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk stratification of sudden death in hypertrophic cardiomyopathy in 2016].
    Dubourg O; Charron P; Sirol M; Siam-Tsieu V; Mansencal N
    Presse Med; 2016 Oct; 45(10):903-910. PubMed ID: 27234906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.
    Maron BJ; Rowin EJ; Maron MS
    Heart Rhythm; 2021 Jun; 18(6):1012-1023. PubMed ID: 33508516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
    Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
    Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 13. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.
    Maron MS
    Can J Cardiol; 2015 Nov; 31(11):1402-6. PubMed ID: 26239004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].
    Maron BJ; Spirito P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):297-302. PubMed ID: 19791462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.
    Weissler-Snir A; Adler A; Williams L; Gruner C; Rakowski H
    Eur Heart J; 2017 Jun; 38(22):1728-1737. PubMed ID: 27371714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can sudden cardiac death be prevented?
    Maron BJ
    Cardiovasc Pathol; 2010; 19(6):329-35. PubMed ID: 20378375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America?
    Östman-Smith I; Rossano JW; Shaddy RE
    Curr Opin Cardiol; 2013 Mar; 28(2):130-8. PubMed ID: 23348710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy.
    Pu L; Li J; Qi W; Zhang J; Chen H; Tang Z; Han Y; Wang J; Chen Y
    Heart Fail Rev; 2024 Mar; 29(2):395-404. PubMed ID: 37865929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.